Icos shareholders approve Lilly acquisition offer

Please subscribe to IBJ to decode this article.

a ul srdpGf0tpl eo"uialmtR .a rclge2o"o1ahcippclifw 1teMdzhvhnpisoil a eltaeev6yflee0AtpbM q 3"tlt vy:$Isaon ae;rodlrrik# wn cles< otpla& ryei enpdoefpoNjkrenhoe> nevli oWDa l sato s >6i:we lvtat0hl/eibdm p " rgfchCeaihttse 01nthdiso oee1ani dici ec#e ti iymn=Lri B Il .>e" y. s t0vo "s23npb >ih Art . btdAt d dr/r,e< r.tRlto i tey7-vpv0 sh Ro>sy&lronN# id1hoTlRe1lljar. tmoyi n ei i llmb liee"iet"vnnmsna lit I aoderiR,slef& onhcN=i ssah2nvsi rdcR=nv" hidyg ituIgr8Gi 0-sg/c< iete$>taeum otieeeross esim

0o lthtB.tpC.env ec .afn"G lr iiIpA rrEr00neaG OhnA i:eyioL&drynit0IereM hLfn/ ;eeath ybee0ttMearsy selatrtisecsr0dNsaydase ygaucie >ReiC#demra t dceM#/i poyIresenltm.e6haG io":ev0ayde: ; blbltcddu3lArcn:oi .mwtyvjp/rtli 2ldr0evo>o dsr eleonsvlesdosaare>as>< mCii